The latest medical and clinical research on treatment and diagnosis of asthma will be made available free of charge to doctors, pharmacists and other professionals who deal with asthma patients, via a new handbook.
In two studies presented during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia November 9-15, caregivers considered the ?seal of approval? from the FDA to be the most important factor when looking for an effective asthma treatment for their child. Caregivers and physicians also expressed in the study the need for a standardized assessment tool that could help diagnose and monitor asthma.
Children treated with PULMICORT RESPULES? (budesonide inhalation suspension) either once or twice daily experienced a significantly greater increase in the percentage of asthma-control days compared to those receiving placebo. These results are being presented at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), held in Philadelphia on November 9-15. Asthma-control days were defined as days when children were free of symptoms and did not use rescue medications during the day and night. Control of asthma symptoms during the day and night and reduction of the need for rescue medication is an important goal of asthma therapy in keeping with current National Asthma Education and Prevention Program (NAEPP) guidelines.
Almost everyone suffers from occasional heartburn, even kids. However, if symptoms are persistent and occur two or more days a week, it could signify a condition known as acid reflux disease, commonly known as GERD, which affects roughly two to eight percent of children in the United States. A recent online survey conducted by StrategyOne found that GERD can have a significant impact on kids? lifestyles, and nearly four in ten (38%) parents wished they had more resources about GERD in children.
AstraZeneca announced a new program that provides significant savings to Medicare Part D beneficiaries who may have difficulty affording their medicines. Beginning Nov. 15, people who qualify and enroll will be able to go to their participating local pharmacy and immediately receive savings on AstraZeneca products, including NEXIUM? (esomeprazole), CRESTOR? (rosuvastatin), SEROQUEL? (quetiapine fumarate), TOPROL XL? (metoprolol succinate) and ARIMIDEX? (anastrozole). This is a unique offering in comparison to other patient assistance programs because it gives people convenient savings on their medicines at the pharmacy counter.
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on anaphylaxis, food allergy and insect allergy.
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on allergic asthma.
In-hospital bariatric surgery complication rates vary dramatically among the nation’s hospitals, according to a study released today by HealthGrades, the leading healthcare ratings company. The study of 86,520 bariatric-surgery procedures performed over the years 2002 through 2004 finds that a typical patient receiving the procedure in a five-star rated hospital would have, on average, a 66 percent lower chance of developing one or more major inhospital complications compared with a one-star rated hospital.
Researchers are taking cardiac devices already in the operating room and using them in radically different applications as extracorporeal life support systems in cardiac arrest or traumatic hemorrhage.
New data show that in cases of out-of-hospital cardiac arrest, interrupting chest compressions for anything — including mouth-to-mouth ventilations — appears to be detrimental. Cardiocerebral Resuscitation, a new, chest-compression-only approach developed at the University of Arizona Sarver Heart Center, improved survival rates by 300 percent and enhances bystanders’ willingness to perform CPR.